SARS-CoV-2 in immunocompromised individuals

Immunocompromised individuals and particularly those with hematologic malignancies are at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic deficits that limit prevention, treatment, and clearance of the virus. Understanding the natural history of viral infections i...

Descripción completa

Detalles Bibliográficos
Autores principales: DeWolf, Susan, Laracy, Justin C., Perales, Miguel-Angel, Kamboj, Mini, van den Brink, Marcel R.M., Vardhana, Santosha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468314/
https://www.ncbi.nlm.nih.gov/pubmed/36182669
http://dx.doi.org/10.1016/j.immuni.2022.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468314/
https://www.ncbi.nlm.nih.gov/pubmed/36182669
http://dx.doi.org/10.1016/j.immuni.2022.09.006

Ejemplares similares